EU

In November 2022, the European Commission published a proposal to update current EU design law to adapt it to the digital age. Noa Rubingh outlines the proposed changes and the road to implementation. 

A recent finding of invalidity against sports brand Puma provides a valuable reminder of the need to obtain design registration within the designated 12-month grace period – and to be careful of accidental publication online.

Whether you choose to file a patent application or keep a new invention secret, it’s crucial to take steps to minimise the risks of disclosure. Rose-Marie Ehanno explains how to keep patentable inventions confidential.

When deciding on your IP enforcement and protection strategy, both the 'sword' and 'shield' functions of trademarks must be kept in mind.

Must a compound be shown to be suitable for each disease for first medical use claims to be sufficiently disclosed in applications for European patents, asks Matthieu Boulard. 

The short answer is ‘yes’, you can own a fictional character, says UK Trademark Attorney Luke Portnow, and this summer the UK saw a particularly interesting case law development in copyright protection. 

As the Advocate General issues its opinion in a case concerning design registration of a bike saddle, Volha Parfenchyk discusses what is meant by ‘normal use’ in the context of EU design rights.

Should the trademark owner be held liable for a product defect, even if they did not manufacture the goods? That was the question at the heart of a recent dispute before the Court of Justice of the EU. Noa Rubingh examines the ruling and its implications for trademark owners. 

In a recent webinar on best practices for European patents, Novagraaf’s Dr Kate McNamara joined experts from Questel to discuss the new European patenting landscape. Here, we summarise some of the key points discussed.

The EU General Court has issued its decision in the decade-long dispute over the 'Spinning' trademark, as used for exercise-related goods and services. Aurélie Guetin cycles back to take a look at the proceedings.

As the high-profile ruling in BavariaWeed illustrated earlier this year, many (illegal) drug references, images and terms are not eligible for trademark registration in the EU on the grounds of public order or morality. What can be registered depends largely on the type of drug to which the trademark refers.

On 15 September 2022, our experts discussed best practices for protecting 'non-traditional' trademarks in an increasingly innovative world. Register for our webinar recording to find out more.